Very recently, we reported that serum Mac-2 binding protein (Mac-2bp) levels constitute a superior biomarker for distinguishing NASH from non-NASH patients (manuscript in press). The gene discussed is LGALS3BP; the disease is metabolic dysfunction-associated steatohepatitis.